Patient & Site Solutions Center
One of the most difficult tasks of conducting a clinical trial is the study startup process. That process includes a feasibility study to determine if there are sufficient patients to meet established inclusion and exclusion criteria, site selection, and patient recruitment.
Research has shown that as many as 85 percent of trials fail to meet enrollment timelines and 80 percent fail to finish on time. Additionally, 50 percent of sites selected to participate in studies recruit one or no patients.
Patient recruitment firms and technologies are available to help sponsor companies locate patients for studies. Technology tools such as eDiaries, text reminders, and remote monitoring tools can ease the burden on patients and increase retention rates. Additionally, there are technology tools that notify sponsor companies if and when a patient takes their trial medication. AI and machine learning solutions are also available to mine EHRs and EMRs to locate patients meeting inclusion/exclusion criteria, or to search sites to determine which ones are best suited for a trial.
How can we help?
Looking for help working with Patients or Sites? If you're searching for information or a supplier, let Clinical Leader lend you a hand.
Advarra optimizes compliance and clinical trials as the premier provider of global research compliance services, including IRB, IBC, consulting, and research technology products. Clinical trial sponsors and CROs recognize Advarra as the largest integrated provider of IRB services with the greatest institutional reach among health systems, cancer centers, academic medical centers, and investigators. Forte, now part of Advarra, is the industry’s leading provider of standards-based research technology.
Catalyst Clinical Research is a clinical development organization providing highly customizable solutions to the global biopharmaceutical industry. Built from more than two decades of listening to their customers, devising customer-centric solutions and helping them breakthrough with clinical development programs surrounded by therapeutically aligned teams of experts.
Clinical Ink, a global clinical technology company, offers data certainty from source to submission. Our Lumenis eSource clinical technology and configurable direct data capture, eCOA, ePRO, and eConsent modules — a suite of solutions for capturing and integrating electronic data from sites, clinicians, and patients at its source — naturally enhance your clinical trial workflow by reducing manual labor, providing anytime, anywhere data access, and saving resources as your trials progress.
Cognizant’s Life Sciences business unit partners with biopharmaceutical and med-tech companies to develop strategies and apply solutions to healthcare challenges across the value chain. Our services and products, including the Cognizant® Shared Investigator Platform (SIP), are digitizing interactions between sponsors and investigators across every phase, helping the industry subtract time from clinical development and add it to patient lives.
Complion’s mission is to transform the way clinical trial documentation is maintained and shared. By re-engineering cumbersome compliance processes, we seek to unleash medical innovators to better focus on advancements that improve patient outcomes, and enhance the reputations of institutions and investigators.
Complion provides a cloud-based eRegulatory platform that improves efficiency, compliance and transparency for Research Sites, Sponsors, and CROs. We are continuously improving our platform and processes in response to our clients’ needs.
Datacubed Health is the industry’s only technology solution with out-of-the-box features to support the patient journey with eCOA, patient engagement, virtual visits, eConsent and case alerts in one, integrated solution.
Datatrak is a global clinical research and development technology platform for site and patient engagement. The Datatrak Enterprise Platform is an easy to use, cloud-based eClinical solution that empowers site and patient users with the following products: Business Intelligence, CTMS, Trial Design, Electronic Data Capture (EDC), Medical Coding, Risk-Based Monitoring, Image Data Capture, Endpoint Adjudication, Randomization, Clinical Supply Inventory, eConsent, ePRO, and eCOA.
Florence accelerates clinical research with innovative solutions to streamline clinical trial site workflows and remote connect sponsors, CROs, and sites for access, monitoring, management, and SDR/V. The Florence platform is the industry standard with more than 7,200 research sites in 27 countries, sponsors and CROs collaborating on its network.
Greenphire is the leader in global clinical trial payment automation. Greenphire’s best-in-class solutions optimize clinical trial performance by streamlining payment workflows from sponsors and CROs to sites and participants. Greenphire’s ClinCard, eClinicalGPS and ConneX solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments and travel globally for both sites and participants.
inSeption distinguishes people as the most impactful variable in the outsourcing equation. Our path-breaking model attracts biopharma companies who demand a partner that shares in their drive to conduct impeccable development and will provide quality and dependable clinical solutions. We offer full outsourcing, consulting services, and functional service provider (FSP) solutions.
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. IQVIA applies human data science — leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science — to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes.
Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostic companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,400 customers and partners access the world's most-used platform for clinical development, commercial, and real-world data.
At Medrio, we believe that clinical trial technology shouldn’t be difficult to use. That’s why our full-service eClinical Data Management suite helps streamline your research and unify your solutions so you have more time to focus on your patients, rather than multiple vendors. Since 2005, our flexible technology has evolved alongside our customers to include an integrated suite of EDC, DDC, eConsent, RTSM, and ePRO/eCOA solutions that support your teams and sites, while reducing patient burden.
As a leader in Life Sciences cloud technology, Oracle Health Sciences’ Clinical One and Safety One are trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance. With over 20 years’ experience, Oracle Health Sciences is committed to supporting clinical development, delivering innovation to accelerate advancements, and empowering the Life Sciences industry to improve patient outcomes.
Parexel is in the business of improving the world’s health. We do this by providing a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments. From clinical trials to regulatory, consulting, and market access, our therapeutic, technical, and functional ability is underpinned by a deep conviction in what we do.
Premier Research recognizes that when an emerging biotech is built around a single asset, focus and flexibility are critical to success. And, since many of our customers require additional infrastructure, we fill in resourcing gaps to help their product reach the patient faster. We are a mid-size CRO and offer strategies that are customized for each program, with tailored processes designed to meet highly specific needs.
Pro-ficiency's mission is to eliminate protocol deviations, one study at a time, by bringing simulation to clinical trials training. The simulation approach tackles the highest risk areas of the study protocol, enabling clinical research teams to exercise critical decision-making in a risk free environment, much like a flight simulator for pilots.
QPS is an award winning, global, full service contract research organization (CRO) delivering the highest quality of discovery, preclinical, and clinical drug development services across the US, Europe and Asia. QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction, wholly owned Phase I clinical sites and turnkey laboratories and facilities. QPS stands tall in its commitment to delivering superior quality, skilled performance and trusted service to its valued customers.
Remarque Systems provides a single, easy-to-use, and effective platform to manage all of your clinical trial data. Remarque Systems brings all your data from different sources together in real time; delivers end-to-end visibility and oversight with data-driven analysis, monitoring, and risk assessment; and drives better-informed decisions with clear and conclusive analytics, reports, and visualizations.
With almost a decade of experience matching and enrolling patients, Trialbee is purpose-built to reduce enrollment risk and efficiently meet global clinical trial timelines. Inspired by the shift from traditional clinical trials to hybrid and decentralized clinical trials, Trialbee has developed a data-science driven patient matching and an analytics-driven enrollment platform to provide a patient-centric journey and lower site-burden. These insights and analytics lead to tangible improvements to patient recruitment and enrollment strategies to optimize clinical trial timelines and gain operational efficiencies.
United BioSource LLC (UBC) is a leading provider of pharmaceutical support services, partnering with life science companies to make medicine and medical products safer and more accessible. UBC is well known for our expertise in generating authoritative, real-world evidence of product effectiveness, safety, and value to assist healthcare decisions and enhance patient care.
Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From early phase and bioanalytical sciences through late phase, post-approval and real-world evidence, we provide world-class, full-service drug development services across a range of therapeutic areas, including central nervous system, cardiovascular, metabolic, general medicine, oncology and rare diseases. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO.